Overview

The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease

Status:
COMPLETED
Trial end date:
2024-06-04
Target enrollment:
Participant gender:
Summary
The objective of this study is to observe the effects of 0.05% cyclosporine eye drops combined with artificial tears on patients with diabetes-associated dry eye, and to monitor changes in ocular surface characteristics and inflammatory cytokines in tears before and after treatment.
Phase:
PHASE4
Details
Lead Sponsor:
Peking University Third Hospital